The observed lower mortality with remdesivir plus dexamethasone in patients on IMV/ECMO "further supports the growing ...
FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra. Novo Nordisk’s American depositary receipts tumbled almost 6% ...
The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called repl ...